| Literature DB >> 24388749 |
Paul Halley1, Beena M Kadakkuzha1, Mohammad Ali Faghihi1, Marco Magistri1, Zane Zeier1, Olga Khorkova2, Carlos Coito2, Jane Hsiao2, Matthew Lawrence3, Claes Wahlestedt4.
Abstract
Apolipoprotein A1 (APOA1) is the major protein component of high-density lipoprotein (HDL) in plasma. We have identified an endogenously expressed long noncoding natural antisense transcript, APOA1-AS, which acts as a negative transcriptional regulator of APOA1 both in vitro and in vivo. Inhibition of APOA1-AS in cultured cells resulted in the increased expression of APOA1 and two neighboring genes in the APO cluster. Chromatin immunoprecipitation (ChIP) analyses of a ∼50 kb chromatin region flanking the APOA1 gene demonstrated that APOA1-AS can modulate distinct histone methylation patterns that mark active and/or inactive gene expression through the recruitment of histone-modifying enzymes. Targeting APOA1-AS with short antisense oligonucleotides also enhanced APOA1 expression in both human and monkey liver cells and induced an increase in hepatic RNA and protein expression in African green monkeys. Furthermore, the results presented here highlight the significant local modulatory effects of long noncoding antisense RNAs and demonstrate the therapeutic potential of manipulating the expression of these transcripts both in vitro and in vivo.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24388749 PMCID: PMC3924898 DOI: 10.1016/j.celrep.2013.12.015
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423